Billionaire George Soros Just Dumped These 3 Dividend Stocks
Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed
Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?
Which Cancer Immunotherapy Will Be the Most Successful?
Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.